Definition
A mixed mesenchymal and epithelial tumour usually with benign endometrial epithelium and low-grade malignant stroma resembling endometrial stromal sarcoma, most commonly arising in the uterus, sometimes in the ovary.
There is a reported association with Tamoxifen therapy.
There is usually a phyllodes-like architecture. Tumour without stromal overgrowth have a stromal component that resembles low-grade endometrial stromal sarcoma, either conventional or with fibroblastic differentiation. Stromal overgrowth gives rise to a component that resembles fibrosarcoma or low grade endometrial stromal sarcoma with fibromyxoid features or high grade endometrial stromal sarcoma, sometimes with rhabdomyoblastic differentiation.
The stromal component shows a similar immunophenotype to low grade endometrial stromal sarcoma.
|
Epithelial component |
Stromal component |
||
1/<=351 |
||||
4/<=351 |
||||
0/<=351 |
||||
0/<=351 |
||||
0/<=351 |
9/121 |
|||
0/<=351 |
||||
33/331 |
3/121 |
|||
0/<=351 |
3/<=351 |
|||
0/<=351 |
1/<=351 |
|||
0/<=351 |
||||
5% median1 |
10% median , 12% mean, range <5% to 40%1 |
Adenofibroma: rare; there is no periglandular condensation of stroma
Carcinosarcoma: both epithelial and stromal components show high-grade malignancy.
Botryoid embryonal rhabdomyosarcoma: usually occurs in the vagina of young girls; the stroma shows a cambium layer of concentration adjacent to epithelium.
Myometrial invasion, and sarcomatous stromal overgrowth are associated with aggressive behaviour.
MUHT/PW Bishop